Prenatal Testing for Down Syndrome

Down syndrome is a genetic condition caused by extra copies of chromosome 21. It results in certain characteristics, including some degree of cognitive disability and other developmental delays. Common physical traits include upward slanting eyes, a flattened bridge of the nose, a single crease on the palm (instead of the usual three) and decreased muscle tone. Not everyone with Down syndrome has all of these traits.

The incidence of Down syndrome in the United States is about 1 in 1,000 births. There is no association between Down syndrome and culture, ethnic group, socioeconomic status or geographic region.

Age-related risks

Generally, the chance of having a baby with Down syndrome is related to the pregnant person's age. Under age 25, the odds are about 1 in 1,400. At age 35, the odds are about 1 in 350. At age 40, the odds are about 1 in 100.

Causes

Down syndrome has three causes (or types):

Trisomy 21. An estimated 95% of people with Down syndrome have trisomy 21, meaning they have three number 21 chromosomes instead of two. A person normally has 23 pairs of chromosomes, each made up of genes. During fertilization of an egg by sperm, the female and male pairs of chromosomes normally split, so that only one chromosome is in each egg or sperm. In trisomy 21, the chromosome 21 pair doesn't split and a double dose goes to the egg or sperm. It's far more common for the extra chromosome to come from the egg – an estimated 95 to 97% of the time.
Translocation. This causes about 3 to 4% of Down syndrome cases. In this type, an extra part of chromosome 21 gets stuck onto another chromosome. In about half of these situations, one parent carries the extra material of chromosome 21 in a "balanced" or hidden form.
Mosaicism. A person with mosaic Down syndrome has an extra chromosome 21 in some but not all cells. (The unaffected cells have the usual chromosome 21 pair.) About 1 to 2% of people with Down syndrome have this type.

Prenatal testing

Screening tests can identify individuals at increased risk of having a baby with Down syndrome. There's no risk of miscarriage from being screened, but the test can't determine with certainty whether the fetus is affected. Diagnostic tests, on the other hand, are accurate at identifying certain abnormalities in the fetus but carry a small risk of miscarriage (generally less than 1%). We offer both screening and diagnostic testing.

Screening tests

All pregnant individuals in California have access to California prenatal screening (CA PNS), also called sequential integrated screening. This noninvasive process is carried out in two steps.

In the first step, which is performed when the pregnancy is between 10 and 14 weeks, a blood sample is taken from the pregnant person and a nuchal translucency ultrasound is performed to measure the fluid at the back of the baby's neck. If the blood test is scheduled prior to the ultrasound, we can provide those results at the end of your ultrasound appointment. The blood test results, nuchal translucency measurement and pregnant person's age are together used to estimate the risk for Down syndrome and trisomy 18 (a genetic condition, also called Edwards syndrome, that affects fetal development).

The second step is a test performed with a blood sample from the pregnant person when the pregnancy is between 15 and 20 weeks. When the results of this blood test are combined with the results from the first trimester blood test and nuchal translucency ultrasound, the detection rate for Down syndrome increases. This test also provides a personal risk assessment for having a fetus with trisomy 18, Smith-Lemli-Opitz syndrome (a genetic condition that can slow growth and cause intellectual disability), an open neural tube defect (a problem with the formation of the embryo's nervous system, such as spina bifida) or an abdominal wall defect (an abnormal opening in the abdomen).

Diagnostic tests

Amniocentesis, chorionic villus sampling (CVS) and ultrasound are the three primary procedures for diagnostic testing.

Amniocentesis is the test we most commonly use to identify chromosomal problems, such as Down syndrome. (In at-risk fetuses, it can be used to detect other genetic diseases, such as cystic fibrosis, Tay-Sachs disease and sickle cell disease.)

An amniocentesis procedure for genetic testing is typically performed when the pregnancy is between 15 and 20 weeks. Under ultrasound guidance, a needle is inserted through the abdomen to remove a small sample of amniotic fluid. Cells from the fluid are cultured and a karyotype test – an analysis of the cells' chromosomal makeup – is performed. It takes about two weeks to receive the results. Amniocentesis detects most chromosomal disorders with a high degree of accuracy.

There is a low risk of miscarriage as a result of amniocentesis – about 1 in 900. Miscarriage rates for amniocentesis performed at UCSF are extremely low.

Like amniocentesis, chorionic villus sampling is most commonly used to identify chromosomal problems, such as Down syndrome. (It can also be used to detect other genetic diseases – including cystic fibrosis, Tay-Sachs disease and sickle cell disease – in at-risk fetuses.) The main advantage over amniocentesis is that CVS is done much earlier in pregnancy, at 10 to 13 weeks rather than 15 to 20 weeks.

CVS involves removing a tiny piece of tissue from the placenta for analysis. Under ultrasound guidance, this sample is obtained either with a needle inserted through the abdomen or a catheter inserted through the vagina and into the cervix (outer end of the uterus). The tissue is cultured and a karyotype test of the cells' chromosomal makeup is performed. It takes about two weeks to receive the results.

While it can provide information earlier in pregnancy than amniocentesis, CVS does not detect spinal cord defects. However, we can screen for spinal cord defects later in the pregnancy using expanded alpha-fetoprotein (AFP) blood testing or ultrasound.

There is a low risk of miscarriage as a result of CVS – about 1 in 450. Miscarriage rates for CVS procedures performed at UCSF are very low.

While the primary purpose of ultrasound is to determine the pregnancy's status – due date, size of the fetus and whether there's more than one baby – ultrasound can also provide some information about possible birth defects. All pregnant UCSF patients undergo a comprehensive ultrasound exam before any invasive tests are performed. We will explain your ultrasound results at the time of your visit.

In some patients, an ultrasound raises concern for a fetal abnormality. This possibility makes ultrasound expertise crucial, so you may find it reassuring that we have extensive experience in performing and interpreting ultrasound exams in pregnancy.

The meaning of a positive result

If you receive positive results on a screening test, we recommend that you discuss its implications and your options with your doctor and a genetic counselor. They will explain what types of diagnostic testing are available. Whether to have invasive genetic testing is your decision.

If a diagnostic test finds a genetic abnormality, we recommend discussing the significance of the result with experts on the condition, including a medical geneticist and a genetic counselor, as well as your doctor.

UCSF Health medical specialists have reviewed this information. It is for educational purposes only and is not intended to replace the advice of your doctor or other health care provider. We encourage you to discuss any questions or concerns you may have with your provider.

Recommended reading

FAQ: Amniocentesis

Amniocentesis is a prenatal diagnostic test that can detect significant chromosome problems. Find frequently asked questions regarding Amniocentesis here.

FAQ: Ashkenazi Jewish Carrier Testing

Screening is offered for eleven genetic disorders which are more common in individuals of Ashkenazi Jewish descent. Learn more and book an appointment here.

FAQ: Carrier Testing for Cystic Fibrosis

Cystic fibrosis (CF) is one of the most common life threatening genetic diseases, affecting approximately 1 out of 3,300 people. Find more info and FAQs here.

FAQ: Carrier Testing for Fragile X Syndrome

Fragile X syndrome is the most common cause of inherited intellectual disability, affecting approximately 1 in 3,600 males and 1 in 6,000 females. Learn more here.

FAQ: Carrier Testing for Spinal Muscular Atrophy

Spinal muscular atrophy (SMA) is a genetic disease that results in progressive muscle weakness and paralysis. Learn more and find FAQs here.

FAQ: Cell-Free DNA Screening

Cell-free DNA screening is a test that can help detect pregnancies with Down syndrome. Learn more and find answers to FAQs.

FAQ: Chorionic Villus Sampling (CVS)

Like amniocentesis, chorionic villus sampling (CVS) can detect significant chromosome problems, such as Down syndrome. Learn more and find FAQs about CVS here.

FAQ: Choroid Plexus Cysts

The presence of isolated choroid plexus cysts (CPCs) on a second trimester ultrasound is a common cause of anxiety. Find frequently asked questions about CPCs.

FAQ: Genetic Carrier Screening

Carrier screening is an optional test to learn about genetic conditions that may affect a pregnancy. Learn more and find FAQs here.

FAQ: Prenatal Tests

Commonly asked questions regarding Prenatal Tests including, types available, positive screenings, diagnostic testing, health insurance coverage, and more.

FAQ: Prenatal Screening Tests

Prenatal screening tests can identify women at high risk for having a baby with certain types of genetic disorders or birth defects. Learn more here.

Related clinic

Prenatal Diagnostic Center

San Mateo Primary and Specialty Care Clinic

1300 S. Eliseo Dr., Suite 200
Greenbrae, CA 94904

(415) 353-3400